Creative Financial Designs’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $297K | Sell |
1,761
-979
| -36% | -$167K | 0.02% | 436 |
|
|
2025
Q4 | $462K | Buy |
2,740
+636
| +30% | +$103K | 0.03% | 337 |
|
|
2025
Q3 | $304K | Buy |
2,104
+705
| +50% | +$96.2K | 0.02% | 399 |
|
|
2025
Q2 | $177K | Hold |
1,399
| – | – | 0.01% | 517 |
|
|
2025
Q1 | $179K | Hold |
1,399
| – | – | 0.01% | 471 |
|
|
2024
Q4 | $185K | Hold |
1,399
| – | – | 0.02% | 453 |
|
|
2024
Q3 | $204K | Buy |
1,399
+50
| +4% | +$7.24K | 0.02% | 446 |
|
|
2024
Q2 | $185K | Sell |
1,349
-1,340
| -50% | -$179K | 0.02% | 447 |
|
|
2024
Q1 | $369K | Buy |
2,689
+2,240
| +499% | +$306K | 0.03% | 305 |
|
|
2023
Q4 | $61K | Buy |
449
+46
| +11% | +$5.61K | 0.01% | 628 |
|
|
2023
Q3 | $49.3K | Sell |
403
-687
| -63% | -$87.4K | 0.01% | 641 |
|
|
2023
Q2 | $138K | Hold |
1,090
| – | – | 0.02% | 415 |
|
|
2023
Q1 | $141K | Hold |
1,090
| – | – | 0.02% | 400 |
|
|
2022
Q4 | $143K | Buy |
1,090
+1
| +0.1% | +$129 | 0.02% | 379 |
|
|
2022
Q3 | $127K | Sell |
1,089
-399
| -27% | -$49.5K | 0.02% | 381 |
|
|
2022
Q2 | $175K | Sell |
1,488
-19
| -1% | -$2.25K | 0.03% | 322 |
|
|
2022
Q1 | $196K | Hold |
1,507
| – | – | 0.03% | 307 |
|
|
2021
Q4 | $230K | Buy |
1,507
+43
| +3% | +$6.66K | 0.03% | 284 |
|
|
2021
Q3 | $237K | Hold |
1,464
| – | – | 0.04% | 274 |
|
|
2021
Q2 | $240K | Buy |
1,464
+1
| +0.1% | +$154 | 0.04% | 267 |
|
|
2021
Q1 | $220K | Hold |
1,463
| – | – | 0.04% | 256 |
|
|
2020
Q4 | $222K | Sell |
1,463
-7
| -0.5% | -$1K | 0.05% | 238 |
|
|
2020
Q3 | $199K | Sell |
1,470
-242
| -14% | -$32.8K | 0.05% | 239 |
|
|
2020
Q2 | $234K | Buy |
1,712
+900
| +111% | +$115K | 0.07% | 196 |
|
|
2020
Q1 | $87K | Hold |
812
| – | – | 0.04% | 185 |
|
|
2019
Q4 | $97K | Sell |
812
-135
| -14% | -$15.1K | 0.04% | 196 |
|
|
2019
Q3 | $92K | Buy |
947
+103
| +12% | +$10.8K | 0.05% | 189 |
|
|
2019
Q2 | $91K | Buy |
844
+58
| +7% | +$6.17K | 0.05% | 185 |
|
|
2019
Q1 | $88K | Hold |
786
| – | – | 0.05% | 177 |
|
|
2018
Q4 | $76K | Sell |
786
-181
| -19% | -$19.2K | 0.06% | 157 |
|
|
2018
Q3 | $118K | Buy |
967
+62
| +7% | +$7.3K | 0.07% | 149 |
|
|
2018
Q2 | $99K | Sell |
905
-60
| -6% | -$6.42K | 0.06% | 179 |
|
|
2018
Q1 | $103K | Sell |
965
-986
| -51% | -$109K | 0.07% | 166 |
|
|
2017
Q4 | $208K | Sell |
1,951
-1,490
| -43% | -$159K | 0.14% | 111 |
|
|
2017
Q3 | $383K | Buy |
3,441
+159
| +5% | +$17K | 0.22% | 98 |
|
|
2017
Q2 | $339K | Sell |
3,282
-51
| -2% | -$5.02K | 0.22% | 98 |
|
|
2017
Q1 | $326K | Buy |
3,333
+855
| +35% | +$81.9K | 0.23% | 102 |
|
|
2016
Q4 | $219K | Buy |
+2,478
| New | +$226K | 0.18% | 110 |
|
Other funds holding IBB
CB
Creative Financial Designs's IBB Position: Q1 2026 in Review
Creative Financial Designs reduced its iShares Biotechnology ETF (IBB) stake by 36% in Q1 2026, selling an estimated $167K and leaving 1,761 shares worth $297K. The position accounts for 0.02% of the portfolio, ranked #436.
Creative Financial Designs first reported a position in IBB in Q4 2016 and has held it in 38 quarters since. The position peaked at $462K in Q4 2025. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.
- Creative Financial Designs held 1,761 shares of iShares Biotechnology ETF worth $297K as of Q1 2026.
- Creative Financial Designs sold 979 iShares Biotechnology ETF shares in Q1 2026, an estimated $167K.
- iShares Biotechnology ETF made up 0.02% of Creative Financial Designs's portfolio in Q1 2026, its #436 holding.
- Creative Financial Designs first reported a position in iShares Biotechnology ETF in Q4 2016 and has held it in 38 quarters since.
- Creative Financial Designs's iShares Biotechnology ETF position peaked at $462K in Q4 2025.
- 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.
Based on Creative Financial Designs's 13F filing for Q1 2026, filed 13 Apr 2026.